Multidrug-resistant Staphylococcus aureus (MDR-SA) poses a critical challenge in both clinical and livestock settings, where conventional antibiotics are increasingly ineffective. To explore alternative strategies, we screened 223 compounds and identified ziyuglycoside II as a promising candidate. Its antibacterial and synergistic effects were evaluated using minimum inhibitory concentration (MIC) and checkerboard assays, biofilm inhibition and clearance tests, and mechanistic analyses of membrane integrity, reactive oxygen species (ROS) generation, membrane potential, and ATP synthesis. Biosafety was assessed through hemolysis and mammalian cytotoxicity assays, and therapeutic potential was examined in Galleria mellonella and mouse endometritis models. Ziyuglycoside II exhibited moderate activity (MIC =32 µg/mL) but showed strong synergy with tetracycline (fractional inhibitory concentration index 0.25-0.375), effectively suppressing resistant and susceptible strains. Time-kill assays revealed a reduction of up to 5 log₁₀ in bacterial counts with the combination. The pairing also inhibited biofilm formation, eradicated mature biofilms, and produced markedly thinner, fragmented biofilm structures under confocal microscopy. Mechanistic studies have demonstrated that ziyuglycoside II potentiates tetracycline by disrupting membrane integrity, inducing ROS accumulation, depolarizing the membrane potential, and impairing ATP synthesis. Importantly, no hemolytic or cytotoxic effects were observed at active concentrations. In vivo, the combination outperformed monotherapy by improving host survival, reducing uterine bacterial burden, and alleviating inflammatory responses. Together, these findings establish ziyuglycoside II as a safe and effective tetracycline potentiator, providing a promising strategy to combat MDR S. aureus infections.
Brucella is a neglected foodborne pathogen, which contaminates milk, dairy products, meat, and meat products of infected animals. However, the role of the Brucella putative effector (BPE) protein family, which relies on the type IV secretion system (T4SS) in Brucella abortus, remains unclear. We demonstrated that BPE159 mediates the regulation of host nuclei in autophagy. The host-interacting protein Eci1 was screened using yeast two-hybridization, molecular docking, and immunoprecipitation, and BPE159-deleted (ΔBPE159) and complementary (ΔBPE159-C) strains were constructed by homologous recombination. We evaluated their growth, survival, and replication and measured the expression of autophagy-related cytokine mRNAs in macrophages. BPE159 was localized in the nucleus of host cells and interacted with Eci1 to downregulate the expression of macrophage autophagy factors, thereby inhibiting host autophagy and enabling the persistence of Brucella. These findings highlight the critical role of BPE159 in mediating autophagy through Eci1 in host cells to promote Brucella survival in host cells.
Porcine epidemic diarrhea virus (PEDV) and transmissible gastroenteritis virus (TGEV) are major causes of viral enteritis in piglets and produce overlapping clinical signs, complicating differential diagnosis in the field. Here, we developed singleplex and duplex visual assays combining reverse transcription multienzyme isothermal rapid amplification (RT-MIRA) with a lateral flow dipstick (LFD) for the detection and differentiation of PEDV and TGEV, targeting the conserved PEDV M gene and TGEV N gene. After screening the primer-probe sets, amplification was performed at 35 °C within 20 min, and the products were read visually on colloidal gold-based strips. No cross-reactivity was observed with reference standards of porcine deltacoronavirus (PDCoV), swine acute diarrhea syndrome coronavirus (SADS-CoV), porcine rotavirus (PoRV), or porcine reproductive and respiratory syndrome virus (PRRSV). Preliminary analytical limits of detection were 2.1 × 101 copies/μL for PEDV and 2.0 × 101 copies/μL for TGEV (approximately 84 and 80 copies per reaction, respectively), as determined with in vitro-transcribed RNA standards. In 50 clinical fecal samples from suckling piglets at three farms in one geographic region, with RT-qPCR as the comparator, RT-MIRA-LFD correctly identified all six RT-qPCR-positive samples, comprising four PEDV single infections, one TGEV single infection, and one mixed infection, and yielded two single-target false-positive results, giving specificities of 97.8% (PEDV) and 97.9% (TGEV); these clinical results should be regarded as preliminary. These findings indicate that RT-MIRA-LFD may provide a rapid and practical tool for the differential detection of PEDV and TGEV in field settings. However, because the TGEV assay targets the N gene, it cannot differentiate TGEV from the closely related porcine respiratory coronavirus (PRCV).
Brucella spp. is a bacterium that can survive under conditions of nutrient starvation and is responsible for foodborne illnesses. The OmpR-type transcriptional regulator is characterized by an N-terminal receiver domain and a C-terminal domain, and it plays a regulatory role in diverse physiological processes, notably nitrogen and carbon metabolism. The genome of Brucella melitensis 16M contains genes for multiple OmpR-family regulators. However, the genetic program associated with nitrogen metabolism remains elusive. Herein, it was demonstrated that the B. melitensis 16M ΔftcR mutant, which lacks the OmpR-type regulator FtcR, displayed compromised viability upon recovery in a nitrogen- and carbon-free medium. Chromatin immunoprecipitation and next-generation sequencing were used to characterize the DNA-binding sites of FtcR. Our genome-wide analysis revealed extensive FtcR-binding sites throughout the B. melitensis 16M genome, including the identification of glnB as a novel target. As glnB encodes a P-II nitrogen regulator, this suggests FtcR plays a direct role in modulating nitrogen, carbon, and energy metabolism under prolonged nutrient starvation. In summary, our findings not only advance our understanding of the transcriptional regulation of nitrogen metabolism but also highlight its critical role in brucellosis pathogenesis, thereby paving the way for the development of novel therapeutics.